Company: DMAAR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026240
Chunk: 461

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 5
Chunk 461
---
 of the audit committee.

Each member of the audit committee is financially
literate, and our board of directors has determined that Mr. Shulgan qualifies as an “audit committee financial expert” as
defined in applicable SEC rules and has accounting or related financial management expertise.

We have adopted an audit committee charter, which
details the purpose and principal functions of the audit committee, including:

●assisting board oversight of (1) the integrity
of our financial statements, (2) our compliance with legal and regulatory requirements, (3) our independent registered public
accounting firm’s qualifications and independence, and (4) the performance of our internal audit function and independent registered
public accounting firm;

●the appointment, compensation, retention, replacement,
and oversight of the work of the independent registered public accounting firm and any other independent registered public accounting
firm engaged by us;

19

●pre-approving all audit and non-audit services
to be provided by the independent registered public accounting firm or any other registered public accounting firm engaged by us, and
establishing pre-approval policies and procedures;

●reviewing and discussing with the independent
registered public accounting firm all relationships the auditors have with us in order to evaluate their continued independence;

●setting clear hiring policies for employees or
former employees of the independent registered public accounting firm;

●setting clear policies for audit partner rotation
in compliance with applicable laws and regulations;

●obtaining and reviewing a report, at least annually,
from the independent registered public accounting firm describing (1) the independent registered public accounting firm’s internal
quality-control procedures and (2) any material issues raised by the most recent internal quality-control review, or peer review,
of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding five years
respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues;

●meeting to review and discuss our annual audited
financial statements and quarterly financial statements with management and the independent registered public accounting firm, including
reviewing our specific disclosures under “Management’s Discussion and Analysis of Financial Condition and Results of Operations”;

●reviewing and approving any related party transaction
required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction;
and

●reviewing with management, the independent registered
public accounting firm, and our legal advisors, as appropriate, any legal,